文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

COVID-19大流行对脊髓灰质炎免疫与监测活动的直接影响

The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
PubMed 文献 · Vaccine · 2021-10-22

本文概述2020年3月至9月COVID-19大流行对全球消灭脊髓灰质炎规划的短期规划与流行病学影响,以及全球消灭脊髓灰质炎行动(GPEI)采取的策略与操作调整。2020年3月至5月,28个国家暂停了共62次脊髓灰质炎疫苗补充免疫活动(SIA);2020年1月至7月全球报告的急性弛缓性麻痹(AFP)病例较2019年同期下降34%。GPEI建议各国自2020年7月起恢复SIA规划与实施,截至2020年9月底,14个国家实施了循环疫苗衍生脊髓灰质炎病毒2型(cVDPV2)疫情应对接种活动,阿富汗和巴基斯坦重启SIA以阻断持续传播的1型野生脊髓灰质炎病毒(WPV1)。

要点

  • 2020年3月至5月,28个国家暂停共62次脊髓灰质炎疫苗补充免疫活动。
  • 2020年1月至7月全球报告AFP病例较2019年同期下降34%。
  • GPEI建议各国自2020年7月起恢复SIA规划与实施,并发布指南确保安全开展。

核心结论

  • COVID-19大流行在2020年3月至9月期间对脊髓灰质炎消灭工作产生了即时的规划与流行病学影响。
  • GPEI采取了适应性策略与操作措施,包括建议自2020年7月起恢复SIA并发布安全实施指南。
  • 对消灭工作的更长期影响仍有待确定,尤其是对脊髓灰质炎病毒流行病学的影响。

研究设计与样本

  • 本文为概述性文章,总结2020年3月至9月COVID-19大流行对脊髓灰质炎消灭工作的即时规划与流行病学影响及GPEI的应对措施。

主要发现

  • 2020年3月至5月,28个国家暂停了共62次脊髓灰质炎疫苗补充免疫活动。
  • 2020年1月至7月全球报告的急性弛缓性麻痹(AFP)病例较2019年同期下降34%。
  • 非洲和东地中海区域关键地区每个活跃监测点收集的环境样本平均数量有所下降。
  • 截至2020年9月底,14个国家实施了cVDPV2疫情应对接种活动,阿富汗和巴基斯坦重启SIA以阻断持续传播的WPV1。

关键数值与推荐

  • GPEI建议各国应自2020年7月起恢复SIA的规划与实施。
  • GPEI发布指南以确保SIA对一线工作人员和社区可安全开展。

临床怎么用

  • GPEI建议各国应自2020年7月起恢复SIA的规划与实施,并遵循其发布的安全实施指南。
  • GPEI最初将规划资源转用于应对COVID-19,同时努力继续必要的脊髓灰质炎病毒监测功能。

局限性

  • 对消灭工作的更长期影响仍有待确定,尤其是对脊髓灰质炎病毒流行病学的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In addition to affecting individual health the COVID-19 pandemic has disrupted efforts to deliver essential health services around the world. In this article we present an overview of the immediate programmatic and epidemiologic impact of the pandemic on polio eradication as well as the adaptive strategic and operational measures taken by the Global Polio Eradication Initiative (GPEI) from March through September 2020. Shortly after the World Health Organization (WHO) declared a global pandemic on 11 March 2020, the GPEI initially redirected the programme's assets to tackle COVID-19 and suspended house-to-house supplementary immunization activities (SIAs) while also striving to continue essential poliovirus surveillance functions. From March to May 2020, 28 countries suspended a total of 62 polio vaccine SIAs. In spite of efforts to continue poliovirus surveillance, global acute flaccid paralysis (AFP) cases reported from January-July 2020 declined by 34% compared with the same period in 2019 along with decreases in the mean number of environment samples collected per active site in the critical areas of the African and Eastern Mediterranean regions. The GPEI recommended countries should resume planning and implementation of SIAs starting in July 2020 and released guidelines to ensure these could be done safely for front line workers and communities. By the end of September 2020, a total of 14 countries had implemented circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak response vaccination campaigns and Afghanistan and Pakistan restarted SIAs to stop ongoing wild poliovirus type 1 (WPV1) transmission. The longer-term impacts of disruptions to eradication efforts remain to be determined, especially in terms of the effect on poliovirus epidemiology. Adapting to the pandemic situation has imposed new considerations on program implementation and demonstrated not only GPEI's contribution to global health security, but also identified potential opportunities for coordinated approaches across immunization and health services.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Burkholder B, Wadood Z, Kassem AM, et al. The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities. Vaccine. 2021. PMID: 34756614. doi:10.1016/j.vaccine.2021.10.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。